Christine Stegling, Executive Director of ITPC global team, to move on
After two years successfully leading the global network of HIV treatment advocates, International Treatment Preparedness Coalition (ITPC), Christine Stegling is to move on.
“Christine helped guide ITPC through a momentous period of change coming on board when the HIV movement was facing serious challenges,” explains Chair of the Board, Gregg Gonsalves. “With Christine at the helm, ITPC has become a stronger global advocacy voice, solidifying its position as a strategic and influential player in the global HIV movement, while at the same time ensuring that organizational structures are strengthened. ITPC is now able to engage more actively in advocacy at regional and international levels ensuring the voices of grassroots activists are heard at the top tables.”
Gregg Gonsalves says ITPC is much strengthened
Christine has built the organization’s advocacy capacity with new professional staff, leading our two major campaigns on intellectual property and viral load monitoring, and a new communications lead helping us to strengthen the impact of our advocacy work and communications. Solange Baptiste, continues in her post as Director of Global Programs and Advocacy, providing ITPC with much needed continuity and program direction at this critical time.
Christine has helped begin the process of moving some of ITPC operations away from our fiscal sponsor, Tides in the US, and establish ITPC as an independent legal entity in Botswana. This process will continue. Christine will remain in post until the end of 2015 to work with the board and staff for a smooth transition. Christine will become the new Executive Director of the International HIV/AIDS Alliance from January 2016. You can see the Alliance statement here.
”I have really treasured my time working for the only global network of treatment advocates,” said Christine. “ITPC is in great shape and I know it will continue to strengthen the capacity of treatment advocates and networks and to shape the HIV response.”